Biogen (BIIB) option IV elevated

Biogen (NASDAQ: BIIB) September weekly call option implied volatility is at 111, October is at 99; compared to its 52-week range 29 to 73 into topline phase 3 data for Alzheimer's drug lecanemab.

You May Also Be Interested In

• Market Vectors Gold Miners ETF (GDX) call put ratio 3.1 calls to 1 put with a focus on August 7 weekly calls as share price up 4.1%
• Alcoa (AA) September 60 calls active, share price up 4.3%
• Arm Holdings (ARM) call put ratio 1.2 calls to 1 put amid wide price movement